Hatchless directs the contents of table eggs toward producing any tissue, cell type, or protein of interest using patent-pending technologies grounded in principles of engineering, biotechnology, and mechanobiology.

Dr. Afshin Safavi is a distinguished biotech entrepreneur and CEO known for developing multiple marketed drugs. He holds a B.S. from UCLA and a Ph.D. from the University of Kentucky Medical School. Safavi founded BioAgilytix Labs in 2008, growing it into a multi-billion dollar international contract research organization (CRO). He now leads Colorado Health & Tech Centers (CHTC), and invests through Summit Impact Partners.

Babak Kia is an entrepreneur, investor, and Senior Lecturer at Boston University with over two decades of experience in deep-tech sectors including AI, biotech, and robotics. A multi-time founder who propelled two companies to Series B funding, he mentors startups and teaches engineering, balancing academic theory with real-world applications and focusing on technology with positive global impact.

Dr. Rouzbeh R. Taghizadeh is a prominent scientist and entrepreneur with over two decades of experience in the field of regenerative medicine, stem cell therapeutics, and bioengineering. He holds a Ph.D. in Stem Cell Bioengineering from the Massachusetts Institute of Technology (MIT).

Dr. Vahied Hossaini has 15+ years expertise in Tissue Engineering, is the Principal Inventor of 20 foundational patents in the space. He has deep domain knowledge in all aspects of cell, tissue & biologics manufacturing. He holds Ph.D. in bioengineering from Swiss Federal Institute of Technology, ETH Zurich.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.